Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

865.82 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,082
Open 865.82
Bid (Size) 872.50 (1)
Ask (Size) 873.80 (1)
Prev. Close 865.82
Today's Range 865.82 - 865.82
52wk Range 434.34 - 882.14
Shares Outstanding N/A
Dividend Yield 0.52%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
The integration of AI and healthcare is well underway. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Trending Stocks With Momentum on Their Side
Trending stocks offer an opportunity to ride momentum higher and create quick returns for daring investors. 
Via InvestorPlace

Performance

YTD
+46.20%
+46.20%
1 Month
+14.27%
+14.27%
3 Month
+14.69%
+14.69%
6 Month
+48.06%
+48.06%
1 Year
+94.43%
+94.43%

More News

Read More
3 Must-Buy Stocks Before the Third Quarter
Via InvestorPlace
Is Eli Lilly the Best Pharmaceutical Stock for You?
Via The Motley Fool
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Via Benzinga
Exposures Product Safety
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Via Benzinga
Eli Lilly Has Likely Blockbuster Drug, Elevated To Stock Spotlight: Joins These Names Just Added To IBD's Top Screens
Via Investor's Business Daily
Eli Lilly's Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst
Via Benzinga
Exposures Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
Via Investor's Business Daily
Exposures Product Safety
Why Are Stocks Down Today?
Via InvestorPlace
Eli Lilly Stock Hits New 52-Week High as FDA Panel Recommends Alzheimer’s Drug
Via InvestorPlace
Exposures Product Safety
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
Via FinancialNewsMedia
Exposures Product Safety
Top 4 Health Care Stocks That May Keep You Up At Night This Month
Via Benzinga
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
From FN Media Group LLC
Via GlobeNewswire
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
Via Benzinga
Exposures Product Safety
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Via The Motley Fool
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
Via The Motley Fool
Apple, Meta, Celsius, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
7 Over-Hyped Stocks to Sell Before They Plunge: June Edition
Via InvestorPlace
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
Via Investor's Business Daily
Exposures Product Safety
What's Happening With Eli Lilly Shares On Monday?
Via Benzinga
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Via Investor's Business Daily
Exposures Product Safety
7 Blue-Chip Stocks to Add to Your June Buy List
Via InvestorPlace
The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.